ValuEngine Lowers Safeguard Scientifics, Inc. (SFE) to Strong Sell

ValuEngine downgraded shares of Safeguard Scientifics, Inc. (NYSE:SFE) from a sell rating to a strong sell rating in a report issued on Tuesday, May 16th.

Separately, Zacks Investment Research upgraded Safeguard Scientifics from a hold rating to a buy rating and set a $14.00 price objective for the company in a report on Wednesday, March 15th.

Safeguard Scientifics (NYSE SFE) opened at 11.20 on Tuesday. The stock has a 50 day moving average price of $11.50 and a 200 day moving average price of $12.24. Safeguard Scientifics has a 52-week low of $10.60 and a 52-week high of $14.38. The company’s market capitalization is $228.02 million.

Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings data on Friday, April 28th. The asset manager reported ($1.08) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.53) by $0.55. During the same quarter last year, the business posted ($0.76) earnings per share. Analysts anticipate that Safeguard Scientifics will post ($2.23) EPS for the current fiscal year.

WARNING: “ValuEngine Lowers Safeguard Scientifics, Inc. (SFE) to Strong Sell” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/06/17/safeguard-scientifics-inc-sfe-downgraded-to-strong-sell-at-valuengine-updated-updated-updated.html.

Hedge funds have recently modified their holdings of the stock. KBC Group NV boosted its stake in shares of Safeguard Scientifics by 47.5% in the first quarter. KBC Group NV now owns 9,447 shares of the asset manager’s stock worth $120,000 after buying an additional 3,044 shares during the period. American International Group Inc. boosted its stake in shares of Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock worth $158,000 after buying an additional 833 shares during the period. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in shares of Safeguard Scientifics during the third quarter worth approximately $159,000. Goldman Sachs Group Inc. boosted its stake in shares of Safeguard Scientifics by 12.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock worth $195,000 after buying an additional 1,754 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in shares of Safeguard Scientifics by 5.2% in the first quarter. Wells Fargo & Company MN now owns 15,951 shares of the asset manager’s stock worth $203,000 after buying an additional 791 shares during the period. 76.66% of the stock is currently owned by institutional investors and hedge funds.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply